ME Therapeutics Holdings Inc.
METX
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -54.64% | -5.79% | -7.93% | 2.45% | 39.49% |
| Total Receivables | 58.58% | 98.42% | 303.25% | 155.21% | 186.44% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.62% | -73.42% | 20.86% | 816.00% | 615.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -50.85% | -7.84% | -4.10% | 5.32% | 43.74% |
|
|
|||||
| Total Current Assets | -50.85% | -7.84% | -4.10% | 5.32% | 43.74% |
| Net Property, Plant & Equipment | -3.94% | 98.75% | 179,300.00% | 165,900.00% | 170,000.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.67% | 0.00% | -- | -- | -- |
| Total Assets | -45.67% | -0.14% | 12.32% | 19.50% | 61.41% |
|
|
|||||
| Total Accounts Payable | 982.46% | 46.43% | 230.41% | 229.70% | -- |
| Total Accrued Expenses | -54.28% | -47.60% | -13.71% | -10.28% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.43% | 7.87% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 296.30% | -- |
| Total Other Current Liabilities | -- | -- | -- | 296.30% | -- |
| Total Current Liabilities | 62.55% | 25.92% | 283.26% | 207.58% | -- |
|
|
|||||
| Total Current Liabilities | 62.55% | 25.92% | 283.26% | 207.58% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.09% | -5.11% | 300.21% | 264.72% | -- |
|
|
|||||
| Common Stock & APIC | 9.88% | 46.34% | 38.06% | 39.40% | 77.28% |
| Retained Earnings | -20.73% | -13.71% | -11.96% | -13.26% | -9.98% |
| Treasury Stock & Other | -2.51% | -39.76% | -33.45% | -29.86% | -45.20% |
| Total Common Equity | -49.69% | 0.72% | 0.05% | 12.44% | 51.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.69% | 0.72% | 0.05% | 12.44% | 51.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -49.69% | 0.72% | 0.05% | 12.44% | 51.39% |
|
|
|||||